Intrahepatic hepatitis B virus replication and liver histology in subjects with occult hepatitis B infection  D.K.-H. Wong, J. Fung, C.-K. Lee, W.-K.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
R. Cavallo  Clinical Microbiology and Infection 
Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013  J. Verschueren, L. Cnops,
Evolution of the incidence of hepatitis B virus infection and immunization rates in a large French cohort born between 1960 and 1994  C. Ramière, L. Roche,
Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience  M.-C.
Core I97L mutation in conjunction with P79Q is associated with persistent low HBV DNA and HBs antigen clearance in patients with chronic hepatitis B 
Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C  C. Sagnelli, M. Merli, C. Uberti-Foppa, H. Hasson,
H. Lepidi, F. Gouriet, D. Raoult  Clinical Microbiology and Infection 
I.J. Schalk  Clinical Microbiology and Infection 
Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care  S. Chevaliez,
D. Khalil, M. Hultin, M.U. Rashid, B. Lund 
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Migrant health—a cause for concern?
The relationship between tumour necrosis factor-α gene polymorphism and susceptibility and clearance of the persistent hepatitis B virus infection in.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Hepatitis B and C virus-related carcinogenesis
Infectious causes of cancer: an evolving educational saga
Virological tools to diagnose and monitor hepatitis C virus infection
Hepatitis B virus basal core promoter/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection  Y.W.
Risk factors and outcome for colistin-resistant Acinetobacter nosocomialis bacteraemia in patients without previous colistin exposure  Y.-C. Wang, Y.-T.
Volume 68, Issue 3, Pages (March 2018)
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013  L.E.B. Nabarro, R.A. Lever, M. Armstrong,
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B  W.-K. Seto, D. K.-H. Wong,
Reduction of Hepatitis B Surface Antigen and Covalently Closed Circular DNA by Nucleos(t)ide Analogues of Different Potency  Danny Ka-Ho Wong, Wai-Kay.
F. Li, P. Zhou, W. Deng, J. Wang, R. Mao, Y. Zhang, J. Li, J. Yu, F
L. -W. Song, P. -G. Liu, C. -J. Liu, T. -Y. Zhang, X. -D. Cheng, H. -L
Vector control: a cornerstone in the malaria elimination campaign
Comparison of respiratory virus shedding by conventional and molecular testing methods in patients with haematological malignancy  L. Richardson, J. Brite,
A comparison of telbivudine and entecavir in the treatment of hepatitis B e antigen- positive patients: a prospective cohort study in China  Y. Zhang,
Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia  S.-C. Kuo, Y.-T. Lee,
Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panels  B. Sarov, L. Novack, N.
Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination  M.-R. Lee,
C. Fabrizio, A. Procopio  Clinical Microbiology and Infection 
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Clinical and microbiological characteristics of Nocardiosis including those caused by emerging Nocardia species in Taiwan, 1998–2008  C.-K. Tan, C.-C.
Early invasive fungal infections and colonization in patients with cirrhosis admitted to the intensive care unit  E. Theocharidou, B. Agarwal, G. Jeffrey,
A. Pierangeli, F. Cannella, C. Scagnolari, M. Gentile, I. Sciandra, G
Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus.
Metagenomics and probiotics
Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study  J.-Y. Feng, S.-F. Huang, W.-Y. Ting, Y.-C.
Hepatitis B and C virus-related carcinogenesis
Previously unknown species of Aspergillus
Detection of Wolbachia genes in a patient with non-Hodgkin's lymphoma
Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected.
Sexually acquired Zika virus: a systematic review
Systematic review of antibiotic consumption in acute care hospitals
Central venous catheter-related Stenotrophomonas maltophilia bacteraemia and associated relapsing bacteraemia in haematology and oncology patients  C.-H.
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Increased intrahepatic quasispecies heterogeneity correlates with off-treatment sustained response to nucleos(t)ide analogues in e antigen-positive chronic.
S. M. Bartsch, J. A. McKinnell, L. E. Mueller, L. G. Miller, S. K
Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS  M. Rybicka,
Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013  U. Fedeli, E. Schievano,
Statin use and clinical outcomes among pneumonia patients
Ten-year follow-up of hepatitis B relapse after cessation of lamivudine or telbivudine treatment in chronic hepatitis B patients  H.-Y. Pan, H.-Y. Pan,
M.T. Pérez-Rodríguez, A. Sousa, P. Martínez-Cueto, A. Ocampo 
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
J.L. Balcázar  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
CMI readers' survey Clinical Microbiology and Infection
Rajko Saletinger, Mario Poljak, Franc Strle 
The future of diagnostic bacteriology
Presentation transcript:

Intrahepatic hepatitis B virus replication and liver histology in subjects with occult hepatitis B infection  D.K.-H. Wong, J. Fung, C.-K. Lee, W.-K. Seto, J. Leung, F.-Y. Huang, C.-K. Lin, C.-L. Lai, M.-F. Yuen  Clinical Microbiology and Infection  Volume 22, Issue 3, Pages 290.e1-290.e3 (March 2016) DOI: 10.1016/j.cmi.2015.10.036 Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Quantitative levels of intrahepatic total hepatitis B virus (HBV) DNA and covalently closed circular DNA (cccDNA) in patients with chronic hepatitis B (CHB) and in participants with occult hepatitis B infection (OBI). All individual measurements are shown as dots, the lower limits of detection are shown as dashed lines, and the median levels are shown as solid lines. Clinical Microbiology and Infection 2016 22, 290.e1-290.e3DOI: (10.1016/j.cmi.2015.10.036) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions